% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Flechsig:125825,
author = {P. Flechsig and P. Choyke and C. Kratochwil and A. Warth
and G. Antoch and T. Holland-Letz$^*$ and D. Rath and V.
Eichwald$^*$ and P. Huber$^*$ and H.-U. Kauczor and U.
Haberkorn$^*$ and F. Giesel$^*$},
title = {{I}ncreased x-ray attenuation in malignant vs. benign
mediastinal nodes in an orthotopic model of lung cancer.},
journal = {Diagnostic and interventional radiology},
volume = {22},
number = {1},
issn = {1305-3612},
address = {Ankara},
reportid = {DKFZ-2017-01949},
pages = {35 - 39},
year = {2015},
abstract = {Staging of lung cancer is typically performed with
fluorodeoxyglucose-positron emission tomography-computed
tomography (FDG-PET/CT); however, false positive PET scans
can occur due to inflammatory disease. The CT scan is used
for anatomic registration and attenuation correction.
Herein, we evaluated x-ray attenuation (XRA) within nodes on
CT and correlated this with the presence of malignancy in an
orthotopic lung cancer model in rats.1×10⁶ NCI-H460 cells
were injected transthoracically in six National Institutes
of Health nude rats and six animals served as controls.
After two weeks, animals were sacrificed; lymph nodes were
extracted and scanned with a micro-CT to determine their XRA
prior to histologic analysis.Median CT density in malignant
lymph nodes (n=20) was significantly higher than benign
lymph nodes (n=12; P = 0.018). Short-axis diameter of
metastatic lymph nodes was significantly different than
benign nodes (3.4 mm vs. 2.4 mm; P = 0.025). Area under the
curve for malignancy was higher for density-based lymph node
analysis compared with size measurements (0.87 vs. 0.7).XRA
of metastatic mediastinal lymph nodes is significantly
higher than benign nodes in this lung cancer model. This
suggests that information on nodal density may be useful
when used in combination with the results of FDG-PET in
determining the likelihood of malignant adenopathy.},
keywords = {Radiopharmaceuticals (NLM Chemicals) / Fluorodeoxyglucose
F18 (NLM Chemicals)},
cin = {C060 / W240 / E055 / E060},
ddc = {610},
cid = {I:(DE-He78)C060-20160331 / I:(DE-He78)W240-20160331 /
I:(DE-He78)E055-20160331 / I:(DE-He78)E060-20160331},
pnm = {315 - Imaging and radiooncology (POF3-315)},
pid = {G:(DE-HGF)POF3-315},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:26611258},
pmc = {pmc:PMC4712895},
doi = {10.5152/dir.2015.15220},
url = {https://inrepo02.dkfz.de/record/125825},
}